Radhika Lipton, Chief Risk Officer, PCBB
Radhika Lipton Appointed PCBB Chief Risk Officer, Succeeding Esteemed Leader Steve Baca
September 19, 2024 10:45 ET | PCBB
PCBB has announced the appointment of Radhika Lipton as Chief Risk Officer, succeeding Steve Baca, who is retiring after nearly two decades of service.
22157.jpg
United States Fruit Beverages Market Report 2024-2028, with Focus on Leading Players PAI Partners, Coca-Cola/Minute Maid, PepsiCo, Keurig Dr Pepper, Florida's Natural Growers, Welch's, Tree Top & More
September 09, 2024 04:09 ET | Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Fruit Beverages in the U.S. Through 2028: Market Essentials" report from Beverage Marketing has been added to ResearchAndMarkets.com's offering. ...
22157.jpg
Q3 2024 Early Indicators Law Firm Hourly Rate Report: Current Legal Market Trends Revealed with Coverage of 60+ Firms
September 06, 2024 08:55 ET | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Valeo 2024 Early Indicators Law Firm Hourly Rate Report" report has been added to ResearchAndMarkets.com's offering.The Valeo 2024 Early Indicators...
22157.jpg
Comprehensive 2024 U.S. Healthcare Law Firm Hourly Rate Report Featuring Over 230 Firms
September 06, 2024 07:52 ET | Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Valeo 2024 United States Healthcare Law Firm Hourly Rate Report" report has been added to ResearchAndMarkets.com's offering. The latest report on...
Axsome Logo.png
Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
September 04, 2024 07:00 ET | Axsome Therapeutics, Inc.
NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Logo.jpg
Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain
August 21, 2024 09:00 ET | Scilex Holding Company
Scilex today announced that the U.S. Patent and Trademark Office has allowed numerous claims from U.S. patent application no. 17/562,229 and will issue a new patent containing those claims related to...